| scholarly article | Q13442814 |
| P50 | author | Kelly K Hunt | Q90520703 |
| P2093 | author name string | Daniel Candinas | |
| Deborah Stroka | |||
| Markus Wagner | |||
| Bernhard Egger | |||
| Stephan A Vorburger | |||
| Vincent Roh | |||
| Markus Trochsler | |||
| Alexander Laemmle | |||
| Michael Strehlen | |||
| P2860 | cites work | Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer | Q24645461 |
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma | Q29618608 | ||
| Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer | Q33372496 | ||
| A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer | Q33383818 | ||
| Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. | Q34398447 | ||
| Rapamycin: an anti-cancer immunosuppressant? | Q34436339 | ||
| Review article: colorectal cancer chemotherapy | Q35544078 | ||
| Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail | Q35572214 | ||
| Novel functions of TIMPs in cell signaling | Q36471132 | ||
| NCCN Task Force Report: mTOR inhibition in solid tumors. | Q37300114 | ||
| Combined inhibition of MEK and mTOR signaling inhibits initiation and progression of colorectal cancer | Q39887307 | ||
| Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis | Q39887934 | ||
| mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo. | Q39888032 | ||
| Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer | Q40194215 | ||
| The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. | Q40459435 | ||
| Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. | Q40582557 | ||
| Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. | Q40692658 | ||
| Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line | Q40837951 | ||
| Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells | Q40935889 | ||
| Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells | Q43196142 | ||
| Cancer statistics, 2003. | Q43729872 | ||
| Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor | Q43873032 | ||
| Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. | Q44260426 | ||
| Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma | Q44551425 | ||
| Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia | Q44613352 | ||
| Rapamycin has no effect on fibrosis-associated gene expression or extracellular matrix accumulation when administered to animals with established or early allograft vasculopathy | Q44701822 | ||
| Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy | Q44795406 | ||
| Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. | Q45238854 | ||
| Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study | Q46585156 | ||
| Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer | Q46788251 | ||
| Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro | Q58327266 | ||
| Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer | Q63753520 | ||
| High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer | Q63753588 | ||
| K562 cells produce and respond to human erythroid-potentiating activity | Q69827022 | ||
| Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization | Q70169916 | ||
| Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host | Q71865140 | ||
| Antitumor Activities of a Novel Fluoropyrimidine, N4-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (Capecitabine) | Q77087512 | ||
| Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer | Q80379806 | ||
| P433 | issue | 10 | |
| P921 | main subject | sirolimus | Q32089 |
| colorectal cancer | Q188874 | ||
| oxaliplatin | Q422327 | ||
| P304 | page(s) | 1781-1790 | |
| P577 | publication date | 2009-06-30 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1. | |
| P478 | volume | 13 |
| Q92617804 | Animal models of colorectal peritoneal metastasis |
| Q35940535 | Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. |
| Q92633075 | Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer |
| Q33808713 | Insulin and Glucagon Regulate Pancreatic α-Cell Proliferation |
| Q55432763 | Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. |
| Q37594355 | Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway |
| Q50661808 | Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma |
| Q39307167 | Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma |
| Q44000544 | Screening colonoscopy and detection of neoplasia in asymptomatic, average-risk, solid organ transplant recipients: case-control study |
Search more.